Article Details

La Jolla Pharmaceutical (NASDAQ:LJPC) Stock Rating Lowered by Zacks Investment Research

Retrieved on: 2020-12-03 13:30:00

Tags for this article:

Click the tags to see associated articles and topics

La Jolla Pharmaceutical (NASDAQ:LJPC) Stock Rating Lowered by Zacks Investment Research. View article details on hiswai:

Excerpt

<b>AQR Capital Management</b> LLC now owns 23,081 shares of the biopharmaceutical company's stock valued at $98,000 after buying an additional 9,006 ...

Article found on: www.marketbeat.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up